Joseph W La Plume Charles River Laboratories International, Inc. (CRL) insider trading activity

Joseph W La Plume is EVP, Corp Strategy & Develop of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 22,521 shares of CRL, which is worth approximately $4.41 Million. The most recent transaction as insider was on Dec 01, 2022, when has been sold 6,409 shares (Common Stock) at a price of $109.34 per share, resulting in proceeds of $700,760. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.5K

0% 3M change

9.85% 12M change

Total Value Held $4.41 Million

Joseph W LaPlume Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2022	BUY Exercise of conversion of derivative security	$700,760 $109.34 p/Share	6,409 Added 19.39%	26,641 Common Stock
Nov 04 2022	SELL Open market or private sale	$115,536 $216.36 p/Share	534 Reduced 2.57%	20,232 Common Stock
Aug 05 2022	SELL Open market or private sale	$45,226 $226.13 p/Share	200 Reduced 0.95%	20,766 Common Stock
Jul 06 2022	SELL Bona fide gift	-	195 Reduced 0.92%	20,966 Common Stock
May 29 2022	SELL Payment of exercise price or tax liability	$54,503 $244.41 p/Share	223 Reduced 1.04%	21,161 Common Stock
May 28 2022	SELL Payment of exercise price or tax liability	$30,551 $244.41 p/Share	125 Reduced 0.58%	21,384 Common Stock
May 27 2022	BUY Grant, award, or other acquisition	-	1,657 Added 7.15%	21,509 Common Stock
Feb 23 2022	SELL Open market or private sale	$115,636 $292.75 p/Share	395 Reduced 1.95%	19,852 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$91,218 $289.58 p/Share	315 Reduced 1.53%	20,247 Common Stock
Feb 22 2022	SELL Open market or private sale	$115,165 $290.82 p/Share	396 Reduced 1.89%	20,562 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$93,074 $293.61 p/Share	317 Reduced 1.49%	20,958 Common Stock
Feb 18 2022	SELL Open market or private sale	$333,527 $291.8 p/Share	1,143 Reduced 5.1%	21,275 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	$65,421 $88.05 p/Share	743 Added 3.21%	22,418 Common Stock
Feb 14 2022	SELL Bona fide gift	-	150 Reduced 0.69%	21,675 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$1,426,937 $312.24 p/Share	4,570 Reduced 17.31%	21,825 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	11,344 Added 30.06%	26,395 Common Stock
Dec 25 2021	BUY Grant, award, or other acquisition	-	6,771 Added 31.03%	15,051 Common Stock
Nov 22 2021	SELL Bona fide gift	-	182 Reduced 2.15%	8,280 Common Stock
Aug 06 2021	SELL Open market or private sale	$1,493,320 $403.6 p/Share	3,700 Reduced 30.42%	8,462 Common Stock
May 29 2021	SELL Payment of exercise price or tax liability	$75,372 $337.99 p/Share	223 Reduced 1.8%	12,162 Common Stock
May 28 2021	BUY Grant, award, or other acquisition	-	1,124 Added 8.32%	12,385 Common Stock
Feb 25 2021	SELL Open market or private sale	$2,463,095 $281.98 p/Share	8,735 Reduced 43.68%	11,261 Common Stock
Feb 25 2021	BUY Exercise of conversion of derivative security	$242,138 $88.05 p/Share	2,750 Added 12.09%	19,996 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$91,120 $282.98 p/Share	322 Reduced 1.83%	17,246 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$89,331 $283.59 p/Share	315 Reduced 1.76%	17,568 Common Stock

JWL

Joseph W La Plume

EVP, Corp Strategy & Develop

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account